ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $47,000 | +88.0% | 599 | +49.8% | 0.01% | +85.7% |
| Q2 2019 | $25,000 | +150.0% | 400 | +100.0% | 0.01% | +250.0% |
| Q1 2018 | $10,000 | -96.5% | 200 | -96.2% | 0.00% | -96.8% |
| Q3 2017 | $282,000 | -30.2% | 5,300 | -18.5% | 0.06% | +5.1% |
| Q2 2017 | $404,000 | -42.7% | 6,500 | -37.5% | 0.06% | -27.2% |
| Q1 2017 | $705,000 | +169.1% | 10,400 | +181.1% | 0.08% | +138.2% |
| Q3 2016 | $262,000 | -56.1% | 3,700 | -69.7% | 0.03% | -59.0% |
| Q2 2016 | $597,000 | +108.7% | 12,200 | +378.2% | 0.08% | +130.6% |
| Q4 2015 | $286,000 | -67.2% | 2,551 | -71.8% | 0.04% | -64.0% |
| Q3 2015 | $872,000 | – | 9,051 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |